AMR& Diagnostic Frontiers: virtual event

Date/time: 3 March 2022, 15:00–17:00 (CET)

The Longitude Prize (run by Nesta Challenges), CARB-X and FIND, have joined forces for a virtual event in March, AMR& Diagnostic Frontiers: Developing and increasing access to innovative diagnostics in and for low-and-middle-income countries (LMICs).

Event overview:

The new Global Research on Antimicrobial Resistance (GRAM) study in The Lancet revealed that antimicrobial resistance (AMR) has become a leading cause of death worldwide, with more than 1.2 million people dying as a direct result of antibiotic-resistant bacterial infections in 2019.

watch the webinar


Agenda:

Welcome and keynote
How can we create a new dynamic, so that AMR diagnostics are developed and accessible in LMICs? Key highlights and recommendations from The Lancet Commission on Diagnostics.

  • Chair: Bill Rodriguez, CEO of FIND
  • Keynote: Patricia J Garcia, Professor, Universidad Peruana Cayetano Heredia, Peru and Commissioner, The Lancet Commission on Diagnostics

LMIC diagnostic success stories
Diagnostic developers share their success stories of the development, adaptation and rollout of diagnostics in an LMIC setting, including barriers and recommendations for other developers – and their perspectives on how, looking ahead, LMICs can build homegrown innovation capacity to deliver accessible, rapid diagnostics.

  • Chair: Bill Rodriguez, CEO of FIND
  • Hassan Sefrioui, Director & Member of the Executive Board at Moroccan foundation for Advanced Science, Innovation and Research (MAScIR)
  • Shirshendu Mukherjee, Mission Director, Grand Challenges India (DBT-BIRAC-BMGF-Wellcome Trust) and Biotechnology Industry Research Assistance Council (BIRAC), India
  • Cheikh Tidiane Diagne, Head of Operations, diaTROPIX, of the Institut Pasteur de Dakar, Senegal

Technology pipeline: product feedback and market outlook
Companies developing AMR diagnostics for an LMIC setting will present their products to a panel of global health representatives. The panel will share customer-driven feedback on their pitch presentations – before opening up for a Q&A session with all participants.

  • Chair: Erin Duffy, Chief of Research and Development, CARB-X
  • Pitches:
    • Mridu Sinha, Co-Founder and CEO, MelioLabs
    • Tara de Boer, Founder and CEO, BioAmp Diagnostics
    • Sean McHughes, Senior Scientist, DCN Diagnostics
  •  Panel:
    • Alexandre Costa, Health Programme Manager, UNICEF
    • David Ripin, EVP Infectious Diseases & Chief Science Officer, CHAI
    • Jenny Molloy, University of Cambridge and Chair of the Working Group on Diagnostics and Local Production
    • Jorge Matheu, Team Lead and AMR laboratory expert, WHO
    • Katerina Galluzzo, Strategy Manager, Unitaid
    • Otridah Kapona, Infectious Diseases Specialist, Zambia National Public Health Institute (ZNPHI) / AMR National Focal Point & Coordinator, Zambia

Closing remarks

 

More information